Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study - Takeaways - MDSpire

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study

  • By

  • Danbee Kang

  • Sang Eun Yoon

  • Dongwook Shin

  • Jin Lee

  • Yun Soo Hong

  • Se Kyung Lee

  • Jeong Eon Lee

  • Yeon Hee Park

  • Jin Seok Ahn

  • Eliseo Guallar

  • Won Seog Kim

  • Jungho Lee

  • Seok Jin Kim

  • Juhee Cho

  • December 14, 2021

  • 0 min

Share

  • 1

    Non-Hodgkin lymphoma (NHL) is the most common hematologic malignancy, with varying 5-year survival rates based on cancer stage.

  • 2

    Breast cancer survivors may have an increased risk of developing NHL, with studies indicating a 3.5-fold higher risk in Japanese patients.

  • 3

    The study utilized a nationwide cohort from Korea's National Health Insurance Service to evaluate NHL incidence in breast cancer survivors.

  • 4

    Participants included 84,969 breast cancer cases and 1,057,674 non-breast cancer controls, all aged 20 and older.

  • 5

    NHL was confirmed through specific ICD-10 codes in medical claims, ensuring reliable data for the study's findings.

Original Source(s)

Related Content